A federal appeals court in New Orleans ruled on Friday that the Food and Drug Administration (FDA) had overstepped its authority in their ruling that three doctors will be able to move forward with their lawsuit over the use of ivermectin off-label to treat COVID-19.
Dr. Mary Talley Bowden, one of three doctors who initially filed the petition, trumpeted the ruling as a victory for not only the truth, but patient rights.
